![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 211/58 | (2006.01) |
(11) | Patento numeris | 3325444 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16745321.6 |
Europos patento paraiškos padavimo data | 2016-07-19 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-05-30 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-07 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/042933 |
Data | 2016-07-19 |
(87) | Numeris | WO 2017/015272 |
Data | 2017-01-26 |
(30) | Numeris | Data | Šalis |
201562194725 P | 2015-07-20 | US |
(72) |
CARLOS, Marlon , US
TANDEL, Sagun , US
OLSSON, Roger , SE
HILLGREN, Mikael , SE
FLEMING, Matthew, J. , CH
BOUDIER, Andreas, Philipp , CH
WEBER, Beat, T. , CH
|
(73) |
Acadia Pharmaceuticals Inc. ,
12830 El Camino Real, Suite 400, San Diego, CA 92130,
US
|
(54) | METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C |
METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C |